• BMB Reports
• /
• v.42 no.3
• /
• pp.160-165
• /
• 2009

The temperate Staphylococcus aureus phage ${\Phi}11$ harbors cI and cro repressor genes similar to those of lambdoid phages. Using extremely pure ${\Phi}11$ Cro (the product of the ${\Phi}11$ cro gene) we demonstrated that this protein possesses a single domain structure, forms dimers in solution at micromolar concentrations and maintains a largely $\alpha$-helical structure even at $45^{\circ}C$. ${\Phi}11$ Cro was sensitive to thermolysin at temperatures ranging from $55-75^{\circ}C$ and began to aggregate at ${\sim}63^{\circ}C$, suggesting that the protein is moderately thermostable. Of the three homologous 15-bp operators (O1, O2, and O3) in the ${\Phi}11$ cI-cro intergenic region, ${\Phi}11$ Cro only binds efficiently to O3, which is located upstream of the cI gene. Our comparative analyses indicate that the DNA binding capacity, secondary structure and dimerization efficiency of thermostable ${\Phi}11$ Cro are distinct from those of P22 Cro and $\lambda$ Cro, the best characterized representatives of the two structurally different Cro families.

• Proceedings of the Materials Research Society of Korea Conference
• /
• 2003.11a
• /
• pp.217-217
• /
• 2003

초전도체 선재를 제작하기위해 YBa$_2$Cu$_3$$O_{7-x}$ (YBCO) 와 Ni substrates사이의 계면 문제를 해결하기 위한 buffer layer로써 CaRuO$_3$ (CRO) thu film이 제안되었는데, 이런 buffer layer의 조건으로는Ni metal과 YBCO superconductor사이의 화학적 반응이 없어야 하고 metal component가 YBCO로 diffusion되는 것을 막아주어야 하며 substrates의 산화를 막아주어야 한다. 이런 조건을 만족시키는 것 중에서 CRO thin film이 가장 적절하였지만, CRO의 orthorhombic구조의 distortion에 의만 lattice mismatch 문제가 발생하였다. 이러한 문제를 해결하기 위해 이론적인 구조 분석을 통한 CRO의superconductor buffer layer로써의 가능성을 검토해 보는 것이 목적이다.

• Food Science and Industry
• /
• v.48 no.4
• /
• pp.11-15
• /
• 2015

• Journal of environmental and Sanitary engineering
• /
• v.24 no.1
• /
• pp.33-39
• /
• 2009

In order to investigate effect of metal ion and antioxidant on rancidity of crude rapeseed oil (CRO), $Fe^{2+}$, $Cu^{2+}$, $Co^{2+}$, $Ni^{2+}$, $Cr^{2+}$, $Sn^{2+}$, $Mn^{2+}$, $Zn^{2+}$, and antioxidants including BHA, Vitamin C, and Tocopherol were used. The specific gravity and refractive index of CRO were $0.92g/cm^3$ and 1.45, respectively. The chromaticities of light, red, and yellow in CRO were 88.6 and 98.7, respectively. Among various fatty acids, Oleic acid (C18:1) concentration was highest, 62.3% and Linoleic acid (C18:2) concentration was 19.16%. In the case of Linolenic acid (C18:3) and Palmitic acid (C16:0), they were 9.88 and 5.2%, respectively. The concentrations of unsaturated fatty acids and saturated fatty acid were 92.2 and 7.8%, respectively. The degree of expediting rancidity of CRO was an order of $Fe^{2+}$> $Cu^{2+}$> $Cr^{2+}$> $Zn^{2+}$> $Ni^{2+}$> $Al^{2+}$> $Mn^{2+}$> $Mn^{2+}$> $Sn^{2+}$> $Co^{2+}$> $Li^{2+}$. Especially, when $Cu^{2+}$ and $Fe^{2+}$ was used, the peroxide value concentration was about 4.0 fold higher than non addition of them. The inhibition effect of rancidity of CRO using antioxidant with $Cu^{2+}$ and $Fe^{2+}$ was an order of BHA> Vitamin C> Tocopherol.

• The Journal of Korean Institute of Electromagnetic Engineering and Science
• /
• v.14 no.2
• /
• pp.119-126
• /
• 2003

In this paper, a cylindrical cavity resonator oscillator with high Q factor is designed and fabricated to improve the phase noise characteristic. A cavity resonator is coupled to oscillating circuit using aperture hole. Measured results show that the cylindrical cavity resonator oscillator (CRO) for Ku-band has less phase noise than the dielectric resonator oscillator (DRO) with the same oscillating circuit. It has output power of +3.92 dBm at the center frequency 13.4015250 GHz and phase noise of -109 dBc/Hz at 100 kHz offset.

• The Journal of the Korea Contents Association
• /
• v.13 no.4
• /
• pp.281-289
• /
• 2013

As the number of clinical trials conducted in Korea increases, the need of the Electronic Data Capture (EDC) system for effective clinical data management is also increased. Recently, the Korea Food and Drug Association published 'Guideline for the Electronic Clinical Trial Data Management and Processing' and it would be the foundation for establishing regulation of electronic clinical data management. In this research, we conducted the survey regarding adoption rate of EDC system in clinical trials in hospitals, Contract Research Organizations (CRO), and pharmaceutical companies. And the perceived importance and the ease of application for the Guideline were investigated. The adoption rates of EDC system was 77.6% but it mostly applied to less than five trials. Also EDC system was mostly used in phase I and phase II trials and the utilization rate of CRO was the highest. The perceived importance for the Guideline was high among all three organizations but, in case of the perceived ease of its application, CRO was the highest. Also, the perceived importance of the clinical data standard was high and the standard for data collection was mostly required. However, the comprehension for the global standard of the electronic data was relatively low, so that education is required. This result would be the foundation to increase the electronic clinical trials and develop proper regulation and principles for clinical data standards in Korea.

• Journal of Science and Technology Studies
• /
• v.18 no.3
• /
• pp.1-45
• /
• 2018

South Korea has recently emerged as one of the leading countries conducting clinical trials. Seoul, for instance, is now ranked at the top of the list among the cities in the world. This paper examines the rapid growth of research involving human subjects in Korea, not just from the economic perspective (e.g., the growth of global pharmaceutical markets and the subsequent increase in the demand for clinical trials), but from the policy perspective (e.g., the government?s drive to support and promote this field as a new industry). The industrialization of clinical trials in Korea has manifested itself in the rise of international Contract Research Organizations (CRO) doing their business in Korea. They are, figuratively speaking, invited to Korea by the government. This paper intends to uncover and discuss the bioethical issues concerning research on human subjects, the issues that tend to be set aside merely as procedural ones like ??workable documents??. To this end, it investigates the practice of clinical trials by collecting hitherto unherad voices from patient-volunteers, physician-researchers, CRO employees, and government officials. This paper also explores the themes of ??ethical variability?? and ??biocapital?? in order to compare and constrast the case in Korea with those in other countries.

• Life and Agrochemicals
• /
• s.265
• /
• pp.42-45
• /
• 2011

• 대한임상약리학회:학술대회논문집
• /
• 1999.12a
• /
• pp.22-22
• /
• 1999

• Proceedings of the Korea Technology Innovation Society Conference
• /
• 2013.10a
• /
• pp.849-849
• /
• 2013